89 related articles for article (PubMed ID: 28231523)
1. Synergistic effects between a copper-based metal Casiopeína III-ia and cisplatin.
Davila-Manzanilla SG; Figueroa-de-Paz Y; Mejia C; Ruiz-Azuara L
Eur J Med Chem; 2017 Mar; 129():266-274. PubMed ID: 28231523
[TBL] [Abstract][Full Text] [Related]
2. Mixed copper-platinum complex formation could explain synergistic antiproliferative effect exhibited by binary mixtures of cisplatin and copper-1,10-phenanthroline compounds: An ESI-MS study.
Pivetta T; Lallai V; Valletta E; Trudu F; Isaia F; Perra D; Pinna E; Pani A
J Inorg Biochem; 2015 Oct; 151():107-14. PubMed ID: 26021964
[TBL] [Abstract][Full Text] [Related]
3. Development and In Vitro and In Vivo Evaluation of an Antineoplastic Copper(II) Compound (Casiopeina III-ia) Loaded in Nonionic Vesicles Using Quality by Design.
Aguilar-Jiménez Z; González-Ballesteros M; Dávila-Manzanilla SG; Espinoza-Guillén A; Ruiz-Azuara L
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361549
[TBL] [Abstract][Full Text] [Related]
4. Comparison between the antiproliferative effect and intracellular glutathione depletion induced by Casiopeína IIgly and cisplatin in murine melanoma B16 cells.
Alemón-Medina R; Bravo-Gómez ME; Gracia-Mora MI; Ruiz-Azuara L
Toxicol In Vitro; 2011 Jun; 25(4):868-73. PubMed ID: 21354300
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and hematotoxicity of a novel copper-based anticancer agent: casiopeina III-Ea, after a single intravenous dose in rats.
Vértiz G; García-Ortuño LE; Bernal JP; Bravo-Gómez ME; Lounejeva E; Huerta A; Ruiz-Azuara L
Fundam Clin Pharmacol; 2014 Feb; 28(1):78-87. PubMed ID: 22958076
[TBL] [Abstract][Full Text] [Related]
6. Synergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological Origin.
Okon E; Luszczki JJ; Kukula-Koch W; Halasa M; Jarzab A; Khurelbat D; Stepulak A; Wawruszak A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325867
[TBL] [Abstract][Full Text] [Related]
7. Combination of Osthole and Cisplatin Against Rhabdomyosarcoma TE671 Cells Yielded Additive Pharmacologic Interaction by Means of Isobolographic Analysis.
Jarząb A; Łuszczki J; Guz M; Skalicka-Woźniak K; Hałasa M; Smok-Kalwat J; Polberg K; Stepulak A
Anticancer Res; 2018 Jan; 38(1):205-210. PubMed ID: 29277774
[TBL] [Abstract][Full Text] [Related]
8. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
Serova M; Calvo F; Lokiec F; Koeppel F; Poindessous V; Larsen AK; Laar ES; Waters SJ; Cvitkovic E; Raymond E
Cancer Chemother Pharmacol; 2006 Apr; 57(4):491-9. PubMed ID: 16075278
[TBL] [Abstract][Full Text] [Related]
9. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
[TBL] [Abstract][Full Text] [Related]
10. Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines.
Adjei AA; Davis JN; Bruzek LM; Erlichman C; Kaufmann SH
Clin Cancer Res; 2001 May; 7(5):1438-45. PubMed ID: 11350915
[TBL] [Abstract][Full Text] [Related]
11. Synergistic anticancer activity of Thiazolo[5,4-b]quinoline derivative D3CLP in combination with cisplatin in human cervical cancer cells.
González-Sánchez I; Lira-Rocha A; Navarrete A; Loza-Mejía MA; Coronel-Cruz C; Mendoza-Rodríguez CA; Cerbón MA
Anticancer Res; 2012 Dec; 32(12):5159-65. PubMed ID: 23225412
[TBL] [Abstract][Full Text] [Related]
12. Uniform potent activity of the antiproliferative metal chelate trans-bis(resorcylaldoximato)copper(II) against a large panel of human tumor cell lines in vitro.
Elo H
Chemotherapy; 2004 Nov; 50(5):229-33. PubMed ID: 15528888
[TBL] [Abstract][Full Text] [Related]
13. Strong effect of copper(II) coordination on antiproliferative activity of thiosemicarbazone-piperazine and thiosemicarbazone-morpholine hybrids.
Bacher F; Dömötör O; Chugunova A; Nagy NV; Filipović L; Radulović S; Enyedy ÉA; Arion VB
Dalton Trans; 2015 May; 44(19):9071-90. PubMed ID: 25896351
[TBL] [Abstract][Full Text] [Related]
14. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
Foroodi F; Duivenvoorden WC; Singh G
Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Antiproliferative Effects of a New Cucurbitacin B Derivative and Chemotherapy Drugs on Lung Cancer Cell Line A549.
Marostica LL; Silva IT; Kratz JM; Persich L; Geller FC; Lang KL; Caro MS; Durán FJ; Schenkel EP; Simões CM
Chem Res Toxicol; 2015 Oct; 28(10):1949-60. PubMed ID: 26372186
[TBL] [Abstract][Full Text] [Related]
16. A tri-copper(II) complex displaying DNA-cleaving properties and antiproliferative activity against cancer cells.
Suntharalingam K; Hunt DJ; Duarte AA; White AJ; Mann DJ; Vilar R
Chemistry; 2012 Nov; 18(47):15133-41. PubMed ID: 23059789
[TBL] [Abstract][Full Text] [Related]
17. Synergy, Additivity, and Antagonism between Cisplatin and Selected Coumarins in Human Melanoma Cells.
Wróblewska-Łuczka P; Grabarska A; Florek-Łuszczki M; Plewa Z; Łuszczki JJ
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430369
[TBL] [Abstract][Full Text] [Related]
18. Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro.
Yerushalmi R; Nordenberg J; Beery E; Uziel O; Lahav M; Luria D; Fenig E
Exp Oncol; 2007 Jun; 29(2):126-31. PubMed ID: 17704745
[TBL] [Abstract][Full Text] [Related]
19. An in vitro investigation of the induction of apoptosis and modulation of cell cycle events in human cancer cells by bisphenanthroline-coumarin-6,7-dioxacetatocopper(II) complex.
Thati B; Noble A; Creaven BS; Walsh M; Kavanagh K; Egan DA
Chem Biol Interact; 2007 Jun; 168(2):143-58. PubMed ID: 17512508
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interaction between a mixed ligand copper (II) chelate complex and two anticancer agents in T47D human breast cancer cells in vitro.
Geromichalos GD; Trafalis DT; Katsoulos GA; Papageorgiou A; Dalezis P; Triandafillidis EB; Hadjikostas CC; Athanassiou A
J BUON; 2006; 11(4):469-76. PubMed ID: 17309179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
